• 986 Citations
  • 17 h-Index
20012019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Silvia Nozza is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 54 Similar Profiles
HIV-1 Medicine & Life Sciences
HIV Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
etravirine Medicine & Life Sciences
Italy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 986 Citations
  • 17 h-Index
  • 118 Article

A prospective randomized trial on abacavir/ lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

Mussini, C., Roncaglia, E., Borghi, V., Rusconi, S., Nozza, S., Cattelan, A. M., Segala, D., Bonfanti, P., Biagio, A. D., Barchi, E., Focà, E., Antoni, A. D., Bonora, S., Francisci, D., Limonta, S., Antinori, A., D’Ettorre, G. & Maggiolo, F., Jan 1 2019, In : PLoS One. 14, 9, p. 1-11 11 p., e0222650.

Research output: Contribution to journalArticle

Open Access
Ritonavir
HIV
drugs
CD4 Lymphocyte Count
Pharmaceutical Preparations
2 Citations (Scopus)

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Sgadari, C., Monini, P., Tripiciano, A., Picconi, O., Casabianca, A., Orlandi, C., Moretti, S., Francavilla, V., Arancio, A., Paniccia, G., Campagna, M., Bellino, S., Meschiari, M., Nozza, S., Sighinolfi, L., Latini, A., Muscatello, A., Saracino, A., Di Pietro, M., Galli, M. & 4 others, Cafaro, A., Magnani, M., Ensoli, F. & Ensoli, B., Jan 1 2019, In : Frontiers in Immunology. 10, 1 p.

Research output: Contribution to journalArticle

Open Access
HIV-1
Vaccination
HIV
T-Lymphocytes
DNA

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection

Giacomelli, A., Fabbiani, M., De Benedetto, I., Nozza, S., Focà, E., Celesia, B. M., Marchetti, G., Mussini, C., Antinori, A., d’Ettorre, G., Madeddu, G., Bandera, A., Muscatello, A. & Rusconi, S., Jun 14 2019, In : Journal of Medical Virology. p. 1-15

Research output: Contribution to journalArticle

HIV Infections
Odds Ratio
Confidence Intervals
Therapeutics
HIV

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

ICONA Foundation Study group, Oct 15 2019, In : BMC Public Health. 19, 1, p. 1-13 13 p., 1291.

Research output: Contribution to journalArticle

Open Access
Coinfection
Alcohol Drinking
Liver Diseases
HIV
Physicians
8 Citations (Scopus)

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial

on behalf of the AtLaS-M Study Group, Jul 1 2018, In : Journal of Antimicrobial Chemotherapy. 73, 7, p. 1955-1964 10 p.

Research output: Contribution to journalArticle

Ritonavir
Lamivudine
HIV
Therapeutics
Bone Density